Want to track TARA and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Protara Therapeutics Inc. (TARA) Statistics
Valuation metrics
Market Cap 216.95M
Enterprise value 200.37M
Trailing P/E (ttm) -2.81
Forward P/E -4.02
PEG ratio -0.17
Price/Sales (ttm) -
Price/Book (mrq) 1.44
Enterprise Value/Revenue -
Enterprise Value/EBITDA -2.88
Overview
Shares outstanding 53.59M
Float 52.31M
Shares short 6M
% Held by insiders 0.02%
% Held by institutions 0.82%
Average volume (10 days) 399.08K
Average volume (90 days) 652.55K
Price summary
52-Week low 3.02
52-Week high 7.82
Beta 1.52
50-Day moving average 3.98
200-Day moving average 5.16
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:40
Last split Date 10 Jan 2020
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Dec 2025
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -0.4%
Return on equity -0.42%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -69.69M
Net income to common (ttm) -63.31M
Diluted EPS (ttm) -1.15
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) 135.79M
Total cash per share (mrq) 0.28
Total debt (mrq) 3.06M
Total Debt/Equity (mrq) 0.02
Current ratio (mrq) 10.97%
Book value per share (mrq) 2.64
Cash Flow
Cash flow statement -62.99M
Levered free cash flow (LFCF) -39.34M
